Skip to main content
. 2015 Oct 8;8(1):73–87. doi: 10.1093/jmcb/mjv059

Figure 7.

Figure 7

Functional analysis of aMAB-injected Scga-null mice. Gait (A) and treadmill (B) analyses of Scga-null mice injected with aMABs or aMABs pretreated with DM for 48 h (indicated as aMABs+DM). Treadmill tests were performed at two different time points (15 and 30 days after aMABs or aMABs+DM injections). ***P < 0.001 vs. Sgca-null Day 15; °°°P < 0.01 vs. Sgca-null Day 15; $P < 0.05, $$P < 0.01, $$$P < 0.001 vs. aMABs. Kruskal–Wallis test performed for both analysis scored P = 0.0012.